THC Therapeutics Elects New Directors
| Field | Detail |
|---|---|
| Company | Thc Therapeutics, Inc. |
| Form Type | 8-K |
| Filed Date | Apr 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-change, governance, officer-compensation
TL;DR
THC Therapeutics just swapped out board members, adding Smith and Collins.
AI Summary
THC Therapeutics, Inc. announced on April 2, 2025, a change in its board of directors. The company elected two new directors, Mr. David L. Smith and Mr. Michael J. Collins, to serve until the next annual meeting of stockholders. This filing also disclosed compensatory arrangements for certain officers.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Board changes can introduce uncertainty regarding future strategic direction and operational stability.
Key Players & Entities
- THC Therapeutics, Inc. (company) — Registrant
- David L. Smith (person) — Newly elected director
- Michael J. Collins (person) — Newly elected director
- April 2, 2025 (date) — Date of earliest event reported
FAQ
Who were the newly elected directors for THC Therapeutics, Inc.?
The newly elected directors are Mr. David L. Smith and Mr. Michael J. Collins.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on April 2, 2025.
What is the jurisdiction of incorporation for THC Therapeutics, Inc.?
THC Therapeutics, Inc. is incorporated in Nevada.
What is the IRS Employer Identification Number for THC Therapeutics, Inc.?
The IRS Employer Identification Number is 26-0164981.
What items are covered in this 8-K filing?
This filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2025 by David L. Smith regarding THC Therapeutics, Inc..